Condition: Bladder Cancer, Non-muscle Invasive Bladder Cancer

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT07144319

Sponsor: Photocure

Phase:

Eligibility:

• Age: minimum 18 Years maximum N/A
• Gender: All

Inclusion Criteria:

• Age 18 or older
• Written informed consent, approved by relevant IRB/IEC, signed
• Hexvix/Cysview has been prescribed in the usual manner in accordance with the terms of the marketing authorization (see Appendix B)
• Physician has planned to do a blue light cystoscopy on the patient and to obtain biopsies, if clinically indicated, of suspicious lesions with video confirmation.
• Patient has not previously taken part in this study

Exclusion Criteria:

• None

View trial on ClinicalTrials.gov